453,544 Shares in Mirion Technologies, Inc. (NYSE:MIR) Acquired by Trexquant Investment LP

Trexquant Investment LP acquired a new stake in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 453,544 shares of the company's stock, valued at approximately $7,914,000. Trexquant Investment LP owned about 0.20% of Mirion Technologies at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the stock. Swiss National Bank boosted its stake in Mirion Technologies by 0.5% in the 4th quarter. Swiss National Bank now owns 376,800 shares of the company's stock worth $6,575,000 after purchasing an additional 2,000 shares in the last quarter. Xponance Inc. lifted its stake in shares of Mirion Technologies by 15.9% in the fourth quarter. Xponance Inc. now owns 14,942 shares of the company's stock worth $261,000 after buying an additional 2,048 shares in the last quarter. KBC Group NV grew its holdings in shares of Mirion Technologies by 39.2% during the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock valued at $140,000 after buying an additional 2,254 shares during the last quarter. Pictet Asset Management Holding SA increased its position in shares of Mirion Technologies by 14.2% during the fourth quarter. Pictet Asset Management Holding SA now owns 28,114 shares of the company's stock valued at $491,000 after acquiring an additional 3,496 shares in the last quarter. Finally, Handelsbanken Fonder AB raised its holdings in Mirion Technologies by 10.5% in the 4th quarter. Handelsbanken Fonder AB now owns 61,031 shares of the company's stock worth $1,065,000 after acquiring an additional 5,800 shares during the last quarter. 78.51% of the stock is owned by institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. The Goldman Sachs Group boosted their price target on Mirion Technologies from $16.00 to $21.00 and gave the stock a "buy" rating in a research note on Thursday, December 12th. Baird R W raised shares of Mirion Technologies to a "strong-buy" rating in a report on Thursday, December 19th. Finally, Robert W. Baird cut their target price on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday, April 4th. Three research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $18.75.

Mirion Technologies Stock Performance

Mirion Technologies stock traded up $1.27 during trading on Wednesday, reaching $14.28. The company had a trading volume of 2,844,833 shares, compared to its average volume of 1,661,118. The company has a current ratio of 2.16, a quick ratio of 1.55 and a debt-to-equity ratio of 0.43. The firm's 50-day simple moving average is $15.05 and its 200 day simple moving average is $15.38. The firm has a market capitalization of $3.32 billion, a price-to-earnings ratio of -75.16 and a beta of 0.75. Mirion Technologies, Inc. has a 52 week low of $9.11 and a 52 week high of $18.81.

Mirion Technologies (NYSE:MIR - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The company reported $0.16 earnings per share for the quarter, topping analysts' consensus estimates of $0.14 by $0.02. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. Sell-side analysts forecast that Mirion Technologies, Inc. will post 0.39 earnings per share for the current fiscal year.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.